2017 Community Oncology Conference | COPA

2017 Community Oncology Conference

CLINICAL TRACK

BUSINESS TRACK

ADVOCACY TRACK

WEDNESDAY, APRIL 26, 2017

5:30 – 7:00 PM

Registration & President’s Reception

THURSDAY, APRIL 27, 2017

6:30 – 7:30 AM	Registration & Buffet Breakfast in the Exhibit Hall
7:30 – 7:55 AM	Conference Opening Day One: Welcome from the Co-Chairs – Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network – David Eagle, MD, Lake Norman Oncology – Lucio Gordan, MD, Florida Cancer Specialists & Research Institute – Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology – Jeffrey Patton, MD, Chief Executive Officer, Tennessee Oncology – Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders
7:55 – 8:40 AM	Pharmacy Benefit Managers: Profits Over Patients – Honorable Earl L. “Buddy” Carter, U.S. House of Representatives – Joshua Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network (Moderator) – Steven D’Amato, BS Pharm, Executive Director, New England Cancer Specialists – Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt
8:45 – 9:30 AM	Targeted Therapies & Immunotherapy in Lung Cancer – Craig Reynolds, MD, Florida Cancer Specialists View Presentation >>		Panel Discussion: Early Learnings from the OCM – Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network (Moderator) – Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants – Anne Marie Rainey, MSN, RN, CHC, Compliance & Quality Control Officer, Clearview Cancer Institute	Cancer Care Advocacy 2017: CPAN Goals & Objectives – Rose Gerber, Director of Patient Advocacy, Community Oncology Alliance View Presentation >>
9:45 – 10:30 AM	Keynote Speaker: Scott Hamilton, Olympic Gold Medalist Figure Skater
10:30 – 10:55 AM	Break & Scott Hamilton Q&A in the Exhibit Hall
11:00 – 11:45 AM	Next-Gen Sequencing: State of the Art in Clinical Applications – Howard “Skip” Burris, MD, President, Clinical Operations, Sarah Cannon View Presentation >>	PHARMACY SESSION Pharmacy Accreditation: Needs, Issues & Practical Considerations – Joshua Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network (Moderator) – Bob Phelan, RPh, Chief Executive Officer, Cancer Specialists of North Florida – Tim Safley, MBA, Director, DMEPOS, Pharmacy & Sleep, ACHC View Presentation >>	Big Data in Cancer Care: Is the Rubber Meeting the Road? – Robert Green, MD, Vice President of Clinical Strategy & Senior Medical Director, Flatiron Health	The View from Capitol Hill: Cancer Care Policy & COA’s Priorities – Ted Okon, MBA, Executive Director, Community Oncology Alliance View Presentation >>
11:50 AM – 12:35 PM	Prehabilitation for Cancer Survivors: Concepts & Evidence for Impairment Driven Rehabilitation – Julie K. Sliver, MD, Associate Professor & Associate Chair for Strategic Initiatives, Department of Physical Medicine & Rehabilitation, Harvard Medical School View Presentation >>		Claims Data: How to Analyze, Use, Report & Capitalize on It – Basit Chaudhry, MD, PhD, Tuple Health View Presentation >>
12:35 – 1:30 PM	Lunch & Networking in the Exhibit Hall
1:35 – 2:35 PM	Panel Discussion: Implementing the Practice Vision for the Now & Future of Community Oncology – Terrill Jordan, President & Chief Executive Officer, Regional Cancer Care Associates – Jeffrey F. Patton, MD, Chief Executive Officer, Tennessee Oncology (Moderator) – Bradley Prechtl, MBA, Chief Executive Officer, Florida Cancer Specialists – Jeffrey Vacirca, MD, Chief Executive Officer, NSHOA, a division of New York Cancer & Blood Specialists & President, Community Oncology Alliance			Community Oncology 101: Why Does the Site of Cancer Care Matter? – Betty Apt, Patient Advocate, Northwest Georgia Oncology Centers -Joseph Lynch, MD, Warren Clinic Medical Oncology – Mark Thompson, MD, Past President, Community Oncology Alliance, The Mark H. Zangmeister Center View Presentation >>
2:35 – 3:20 PM	OCM 2.0: The Universal Payment Model – Ted Okon, MBA, Executive Director, Community Oncology Alliance – Kavita Patel, MD, MS, Tuple Health View Presentation >>			Community Oncology 201: Pharmacy Benefit Managers & Impact on Cancer Care – Ray Bailey, RPh, Director of Pharmacy, Florida Cancer Specialists – Joshua Cox, PharmD, BCPS, Director of Pharmacy, Dayton Physicians Network – Stacey McCullough, PharmD, Senior Vice President, Pharmacy Tennessee Oncology View Presentation >>
3:20 – 3:50 PM	Networking & Refreshments in the Exhibit Hall
3:55 – 4:55 PM	Novel Therapies in Brest Cancer: HER2 Amplified, ER+, TNBC Disease – Joyce O’Shaughnessy, MD, Texas Oncology View Presentation >>		Panel Discussion: Update on New Payer Initiatives in Cancer Care – Rene Frick, Senior Director, Provider Network Innovations & Partnerships, BCBS of South Carolina – Robert “Bo” Gamble, Director of Strategic Practice Initiative Community Oncology Alliance (Moderator) – Amanda Joseph, MS-HSM, Senior Affordability of Care Strategy Consultant, Healthcare Service Corporation – Barbara McAneny, MD, Chief Executive Officer, New Mexico Oncology Hematology Consultants – Kashyap Patel, MD, Carolina Blood & Cancer Care	Hands-on Workshop: Effective Advocacy & Lobbying Congress – Jeff Mortier, Principal, Farragut Partners – Honorable Ed Whitfield, Formerly House of Representatives
5:00 – 5:50 PM	Panel Discussion: Employers Discuss Cancer Care & Payment Models – Kembre Roberts, Wellness Manager, Southwest Airlines – John Robinson, President & Chief Executive Officer, RobinsonBush – Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders (Moderator) – Brenna Shebel, Director, National Business Group on Health
5:50 – 6:35 PM	Networking & Refreshments in the Exhibit Hall

FRIDAY, APRIL 28, 2017

6:30 – 7:30 AM	Buffet Breakfast in the Exhibit Hall
7:30 – 8:00 AM	Conference Opening Day Two: Update from the Co-Chairs – Robert Baird, Jr., RN, MSA, CASC, Chief Executive Officer, Dayton Physicians Network – David Eagle, MD, Lake Norman Oncology – Lucio Gordan, MD, Florida Cancer Specialists & Research Institute – Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology – Jeffrey Patton, MD, Chief Executive Officer, Tennessee Oncology – Barry Russo, Chief Executive Officer, The Center for Cancer & Blood Disorders
8:00 – 9:00 AM	Washington DC Update: The Latest Legislative Issues Impacting Cancer Care & Your Practice – Christian Downs, JD, MHA, Executive Director, Association of Community Cancer Centers – Bruce Feinberg, DO, Vice President & Chief Medical Officer, Cardinal Health Speciality Solutions – Ben Jones, Vice President, Government Relations, McKesson Specialty Health & The US Oncology Network – Deborah Kamin, RN, PhD, Vice President, Policy & Advocacy, ASCO – Rita Norton, Senior Vice President, Director of Government Affairs, AmerisourceBergen – Ted Okon, MBA, Executive Director, Community Oncology Alliance (Moderator)
9:00 – 9:45 AM	Panel Discussion: How Community Oncology is Fueling the Cancer Moonshot – William Harwin, MD, President & Managing Partner, Florida Cancer Specialists – Edward Licitra, MD, PhD Chief Financial Officer & Director of Revenue Cycle Central Jersey Division, Regional Cancer Care Associates – Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology (Moderator) – R. Steven Paulson, MD,, President, Texas Oncology
9:45 – 10:10 AM	Break & Networking in the Exhibit Hall
10:15 – 11:00 AM	Myeloma Therapies: New Options & Understanding the Role of Sequencing & Transplantation – Paul G. Richardson, MD, Professor of Medicine, Dana-Farber Cancer Institute View Presentation >>	PHARMACY SESSION Panel Discussion: Oral Adherence & Challenges – Ray Bailey, RPh, Director of Pharmacy, Florida Cancer Specialists – Stacey McCullough, PharmD, Senior Vice President, Pharmacy, Tennessee Oncology – Todd Murphee, PharmD, Ambulatory Pharmacy Manager, Clearview Cancer Institute – Ricky Newtown, CPA, Director of Financial Services & Operations, Community Oncology Alliance (Moderator) View Presentation >>	The Coding Mistress: Actionable Resolution for the Most Common Denials in Oncology – Roberta L. Buell, MBA, Principal, onPoint Oncology LLC	Become a Stronger Advocate: How to Tell Your Story – Rachel Griffith, Senior Director, McCabe Message Partners – Paul Skowronek, Senior Vice President, McCabe Message Partners View Presentation >>
11:05 – 11:50 AM	A Genitourinary Cancer Update: New Therapies – Daniel J. George, MD, Professor of Medicine & Surgery, Duke Cancer Institute View Presentation >>		MACRA, MIPS, & APMs: A Common Sense Approach to Success – Aaron Lyss, Director of Value-Based Care, Tennessee Oncology – Kashyap Patel, MD, Carolina Blood & Cancer Care
11:50 AM – 12:50 PM	Lunch & Networking in the Exhibit Hall
12:50 – 1:35 PM	Low-Grade Non-Hodgkin’s Lymphoma; New Therapies & Updates – Craig Portell, MD, Emily Couric Clinical Cancer Center View Presentation >>	PHARMACY SESSION In-Office Pharmacy/Dispensing: Roadblocks & Legal Issues – Jesse Dresser, Esq., Partner, Frier Levitt – Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt View Presentation >>	Quantifying Physician Performance: Defining the Value Equation – Lalan Wilfong, MD, Texas Oncology	Expanding CPAN: Plans & Discussion – Miriam Yvette Jones Atkins, MD, Augusta Oncology Associates – Michael Diaz, MD, Vice President, Community Oncology Alliance, Florida Cancer Specialists – Rose Gerber, Director of Patient Advocacy, Community Oncology Alliance – Anthony Scalzo, MD, Hematology-Oncology Associates of CNY View Presentation >>
1:40 – 2:25 PM	Biosimilar Check-up: Availability & Clinical/Financial Issues – Edward Li, PharmD, MPH, BCOP, Associate Professor, University of New England College Pharmacy View Presentation >>		Physician Recruitment & Succession Planning: Practical Steps – Barbra McAneny, MD, Chief Executive Officer, New Mexico Oncology Hematology Consultants – Ray Page, DO, PhD, President, The Center for Cancer & Blood Disorders – Robin Zon, MD, FACP, FASCO, Michiana Hematology-Oncology (Moderator)
2:30 – 2:50 PM	Conference Wrap-up: Meeting Observations from the Co-Chairs & Audience